TL;DR The American College of Radiology holds that for people with no symptoms, no risk factors and no relevant family history there is at present not enough evidence to recommend total body screening, and no documented evidence that it saves money or prolongs life. The real cost is not the scan; it is the chain of follow-up the scan can start. Before deciding, separate "no radiation, sees clearly" from "not yet demonstrated".

Why "scan everything at once" sounds so reasonable

The intuition is simple: image the whole body in one go and anything wrong will show up.

And MRI really is excellent at imaging soft tissue. It uses a powerful magnetic field to shift, temporarily, the position of hydrogen atoms that occur naturally in the body; coils in the machine transmit and receive radio waves, and a computer assembles the signal released as the atoms return to their original position into an image [Note 6].

The problem is in the next step of the reasoning. "The image is clear" and "the screening works" are two different things.

Whether screening does good depends on whether it produces an actual health outcome in people without symptoms — earlier treatment, longer life — not simply on whether it can see things.

The ACR position: not that MRI is bad, but that this use of it is unproven

The American College of Radiology at this time does not believe there is sufficient evidence to justify recommending total body screening for people with no clinical symptoms, risk factors or a family history suggesting underlying disease or serious injury; to date there is no documented evidence that total body screening is cost-efficient or effective in prolonging life. [Note 1]

The weight of that sentence falls on the use, not on the machine. The same MRI, used for an examination a doctor has arranged against symptoms or risk, is another matter entirely.

Nor is the position a closed one. The last sentence of the same statement says the College will continue to monitor scientific studies on the utility of screening total body MRI [Note 3] — which is to say the College itself treats this as a question still under watch.

Who most needs to read this: healthy people who want "peace of mind". You are exactly the group the statement is about. Anyone with symptoms or a family history is not in the "screening" category at all, and should go to a doctor for a targeted examination.

That is a different posture from the Government's risk-based targeted screening — bowel, breast and cervical cancer.

Incidental findings: one scan can buy you a chain of tests

Scans frequently turn up large numbers of unexpected, uncertain images. They need further investigation, sometimes invasive procedures, and they bring anxiety, cost and risk.

The ACR, in the same statement, expresses concern on this point — concern, not a claim that it has been demonstrated [Note 2].

Several ideas need keeping apart, because running them together is how this gets misread: an "incidental finding" is an unexpected abnormality found during a scan; "a finding that needs further investigation", "a clinically significant finding", "a confirmed cancer" and "overdiagnosis" are four different things.

And this is a two-sided trade-off, not simply a downside. The ACR's own incidental-findings resource puts both sides in a single sentence: detecting important conditions early, while patients are asymptomatic, may present opportunities for better outcomes and care; but where guidance on effective clinical management is not available, there is also potential for over-testing and over-treatment of incidental findings associated with very low risk [Note 4].

The rest of this article dwells on the consequences, but the potential benefit of early detection belongs in front of you at the same time. An informed choice needs both sides on the table.

"The scan was clear" is not the same as ruling disease out

The risk in the other direction is just as real, and gets mentioned even less than incidental findings.

The ACR position is precisely that total body screening has no documented evidence of effectiveness in prolonging life, so a negative result cannot be treated as a guarantee of health.

Image quality is also subject to practical factors: a clear image depends on holding still and following breath-holding instructions, and metal implants in the body affect imaging too [Note 6].

⚠️ "The scan was clear" means this scan did not see anything, not that there is nothing wrong with you.

MRI itself carries no radiation; chasing an incidental finding may

MRI itself does not use ionising radiation, which distinguishes it from X-rays and computed tomography (CT), and is a genuine advantage.

But the sentence has to be finished. If an incidental finding from the scan needs following up, the subsequent examinations may include imaging that does use radiation, such as CT or X-ray.

So the radiation risk does not sit in the MRI scan; it sits in the chain of tests the scan may open.

If you are having contrast, kidney function is what the boxed warning is about

The good news first: the gadolinium contrast material commonly used in MRI is less likely to cause an allergic reaction than the iodine-based contrast materials used in X-rays and CT [Note 5].

But that cannot be said apart from an exception a regulator has set out in terms.

⚠️ Every gadolinium contrast agent label approved by the US Food and Drug Administration carries a boxed warning — the FDA's highest level of safety alert. Its subject is Nephrogenic Systemic Fibrosis (NSF): patients with severe chronic kidney disease (glomerular filtration rate below 30 mL/min/1.73m²) or acute kidney injury are at increased risk of NSF from gadolinium contrast agents.

With the newer generation of gadolinium agents this is extremely rare, but it is a confirmed complication. A doctor will assess kidney function before injecting contrast.

If you do not know the state of your own kidney function, that is the thing to raise with the doctor before a self-paid scan. Someone without symptoms may well not know whether their kidneys are impaired.

The examination also has limits at the level of experience: you have to keep still and hold your breath on instruction, the enclosed space can be hard on anyone prone to claustrophobia, and metal implants affect imaging or even rule the examination out.

"Is the test safe" and "is it worth having with no symptoms" are two questions. The answer to the first is broadly positive; the second is the one the ACR calls unproven. Confusing them is how "no radiation, very safe" carries someone into a screening with no evidence behind it.

What evidence-based screening looks like: three cancers, three things made explicit

Targeted screening by age and risk: bowel cancer (average-risk people, 50–75), breast cancer (risk-stratified), cervical cancer (25–64, ever sexually active).

The bowel cancer item carries a point that is often misunderstood. "FIT every two years" is an operational design choice of the Government's bowel cancer screening programme, not the only option in the evidence.

For asymptomatic, average-risk people, clinical evidence recognises three approaches:

ApproachFrequency recognised by the evidence
Faecal occult blood test (FOBT)Every year or every two years
SigmoidoscopyEvery five years
ColonoscopyEvery ten years

From among these the Government's programme picked FIT once every two years as its delivery model for average-risk people. So "is there evidence" and "which body picked which specific scheme on which evidence" are two questions to ask separately.

That programme subsidises eligible average-risk people (50–75) for a faecal immunochemical test every two years, with a referral to colonoscopy if positive:

ItemSubsidy
Colonoscopy with polypectomy$8,500
Colonoscopy (no polyp)$7,800
Participant co-payment cap$1,000

This kind of screening has an explicit target group, an explicit pathway and an explicit subsidy. "Whole-body scanning" has none of the three.

Who most needs to read this: people aged 50–75 who have never had bowel cancer screening. Rather than considering a self-paid whole-body scan, the officially subsidised targeted screening is the first step that has evidence and a subsidy behind it.

If you have thought it through and still want to pay for one, what to ask the doctor

The decision should turn on personal risk, not on "the more scanning the more reassurance".

When discussing it with a doctor, ask about all of these together: false positives, incidental findings, follow-up examinations or invasive procedures, contrast risk (where applicable), claustrophobia, cost, and the unproven overall health benefit.

On price, this site assesses no imaging centre, and cites no market survey or average price for whole-body MRI. Whether a health check package includes CT or MRI can be checked item by item in the body-check tool on this site.

One publicly self-reported price point, which is not a market survey and not a recommendation: Trinity Medical Centre publishes on its own website a "Supreme Whole Body Plan" — whole-body MRI, MRA and carotid ultrasound — at $57,000. That is one self-reported price and does not represent a market average; whichever centre you choose, ask that centre directly for its quotation at the time.

What to do next

  1. First ask whether you are the kind of person the ACR is describing. No symptoms, no risk factors, no relevant family history — that statement is about you.
  2. If you have symptoms or a family history, do not take the screening route. Go to a doctor for a targeted examination.
  3. If you are 50–75 and have never had bowel cancer screening, do that first. It has evidence, a subsidy and an explicit pathway.
  4. If you are having contrast, say up front what you know about your kidney function. If you do not know, raise it before the scan.
  5. Keep "no radiation" and "worth having" apart. The first is true; the second is the one the ACR calls unproven.
  6. If you really are going ahead, ask about all seven costs at once. False positives, incidental findings, follow-up tests, contrast risk, claustrophobia, cost, and the unproven benefit.

Frequently asked questions

I have no complaints — is a whole-body MRI a good idea?

For people with no clinical symptoms, no risk factors and no family history suggesting underlying disease or serious injury, the American College of Radiology considers that there is at present not enough evidence to recommend total body screening, and no documented evidence that it is cost-efficient or prolongs life. Whether it suits you is something to discuss with a doctor on your own risk.

Does MRI involve radiation?

MRI itself does not use ionising radiation, which distinguishes it from X-rays and CT. But following up an incidental finding may involve examinations that do use radiation, such as CT or X-ray.

If the scan finds something abnormal, does that mean I am ill?

Not necessarily. Whole-body scans often produce large numbers of unexpected, uncertain "incidental findings" that need further investigation or even invasive procedures. "There is an abnormality on the image" is not the same as having a disease that will affect your health.

So if the scan is clear, can I relax?

No. The ACR position is precisely that total body screening has no documented evidence of effectiveness in prolonging life, so a negative result cannot be treated as a guarantee of health. Image quality itself is also affected by holding still, breath-holding instructions and metal implants in the body.

What should I watch for with contrast?

The gadolinium contrast used in MRI is less likely to cause an allergic reaction than iodine-based contrast, but every FDA-approved gadolinium label carries a boxed warning: patients with severe chronic kidney disease (glomerular filtration rate below 30 mL/min/1.73m²) or acute kidney injury are at increased risk of Nephrogenic Systemic Fibrosis. With newer agents this is extremely rare, but it is a confirmed complication. A doctor assesses kidney function before injecting; if you do not know the state of yours, raise it before the scan.

What does a whole-body MRI cost?

This article cites no market survey or average price for whole-body MRI. It gives one centre's own published price ($57,000) as a reference point only, which does not represent the market level. Whether a health check package includes CT or MRI can be checked item by item in the body-check tool on this site.

What screening does have evidence behind it, then?

Targeted screening by age and risk: bowel cancer (average-risk people, 50–75; the Government's programme uses FIT once every two years as its delivery model, while the evidence itself also includes FOBT, sigmoidoscopy and colonoscopy), breast cancer (risk-stratified) and cervical cancer (25–64, ever sexually active). See this site's articles on each.

What this article does not state
  • This article neither recommends nor opposes any institution, and assesses no imaging centre.
  • Market surveys or average prices for whole-body MRI. This article cites none; the only price in it is one centre's own published figure, which does not represent the market level.
  • Company-sponsored figures that circulate informally. Until the exact study, sample, inclusion criteria and reading definitions can be obtained, this article cites no specific percentage.
  • An incidental-finding rate cannot be converted into overdiagnosis. A high incidental-finding rate can show that the follow-up burden is heavy, but a single observational figure cannot quantify overdiagnosis directly, nor demonstrate an overall mortality benefit.
  • The ACR position is not a closed conclusion. The College says of itself that it will continue to monitor the relevant scientific studies, and this article does not read it as settled.
  • RadiologyInfo content is reviewed periodically by committees of the RSNA, the ACR and the American Society of Radiologic Technologists (ASRT); it is not jointly produced by the three.
  • The source page for the bowel cancer subsidy figures carries an older revision date. The page itself is marked "Last revision date: 6 August 2018"; the amounts were re-checked on 2026-08-10 and still stood, but a reader wanting the current figures should ask the programme directly.

Notes: the official wording

The passages below are quoted verbatim from the sources' own English.

[Note 1] American College of Radiology statement on screening total body MRI, 17 April 2023:

"The American College of Radiology (ACR), at this time, does not believe there is sufficient evidence to justify recommending total body screening for patients with no clinical symptoms, risk factors or a family history suggesting underlying disease or serious injury. To date, there is no documented evidence that total body screening is cost-efficient or effective in prolonging life."

[Note 2] The same statement, expressing concern about the incidental-finding burden:

"In addition, the ACR is concerned that such procedures will lead to the identification of numerous non-specific findings that will not ultimately improve patients' health but will result in unnecessary follow-up testing and procedures, as well as significant expense."

[Note 3] The last sentence of the same statement:

"The ACR will continue to monitor scientific studies concerning the utility of screening total body MRI."

[Note 4] The ACR incidental-findings resource, with both sides inside a single sentence:

"detecting important conditions early, when patients are asymptomatic, may present opportunities for better patient outcomes and care. Furthermore, when guidance is not available on effective clinical management, there is also potential for over-testing and over-treatment of incidental findings associated with very low risk."

[Note 5] RadiologyInfo comparing gadolinium with iodine-based contrast:

"The MRI gadolinium contrast material is less likely to cause an allergic reaction than the iodine-based contrast materials x-rays and CT scanning use."

[Note 6] How MRI forms an image, its lack of ionising radiation, its soft-tissue imaging, and image quality being affected by keeping still, breath-holding instructions and metal implants all come from the same RadiologyInfo page. That page's content is reviewed periodically by committees of the RSNA, the ACR and the American Society of Radiologic Technologists (ASRT); it is not jointly produced by the three. The page itself is marked "Last reviewed on August 05, 2024".

Sources and dates checked

This article was written from the sources listed above. It is about the state of the evidence and the trade-offs; whether you yourself should have this scan, it does not answer — that is for a doctor to decide on your symptoms, risk factors and family history.

Further reading